Article Link: FDA Approves RediTrex (methotrexate) for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Psoriasis NASHVILLE, Tenn...
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease
Article Link: FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease November 25, 2019 — Today, the U.S. Food an...
FDA Approves Exservan (riluzole) Oral Film for the Treatment of Amyotrophic Lateral Sclerosis
Article Link: FDA Approves Exservan (riluzole) Oral Film for the Treatment of Amyotrophic Lateral Sclerosis WARREN, N.J., Nov. 25, 2019 (...
FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults
Article Link: FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults PANGYO, South Korea and PARAMUS, N.J...
FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia
Article Link: FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia 21 November 2019 — AstraZeneca today announced th...
FDA Approves Givlaari (givosiran) for Acute Hepatic Porphyria
Article Link: FDA Approves Givlaari (givosiran) for Acute Hepatic Porphyria CAMBRIDGE, Mass.–(BUSINESS WIRE) November 20, 2019 R...
FDA Approves Abrilada (adalimumab-afzb), a Biosimilar to Humira
Article Link: FDA Approves Abrilada (adalimumab-afzb), a Biosimilar to Humira November 18, 2019 – Pfizer Inc. (NYSE: PFE) today ann...
FDA Approves Adakveo (crizanlizumab-tmca) to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease
Article Link: FDA Approves Adakveo (crizanlizumab-tmca) to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease ...
FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections
Article Link: FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections November 14, 2019 — The ...
FDA Approves Brukinsa (zanubrutinib) for the Treatment of Mantle Cell Lymphoma
Article Link: FDA Approves Brukinsa (zanubrutinib) for the Treatment of Mantle Cell Lymphoma CAMBRIDGE, Mass. and BEIJING, China, Nov. 14...
